People with diabetes lost an average of nearly 20 pounds of body weight during a clinical trial of orforglipron, which is a new small molecule GLP-1 drug.
In an exclusive interview with Business Insider's Mia de Graaf, Sen. Bernie Sanders talks about his push to improve labels on ultra-processed foods across the US, RFK Jr.'s plans to overhaul the industry, and the obesity epidemic.